1. Home
  2. JJSF vs MRUS Comparison

JJSF vs MRUS Comparison

Compare JJSF & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JJSF
  • MRUS
  • Stock Information
  • Founded
  • JJSF 1971
  • MRUS 2003
  • Country
  • JJSF United States
  • MRUS Netherlands
  • Employees
  • JJSF N/A
  • MRUS N/A
  • Industry
  • JJSF Specialty Foods
  • MRUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • JJSF Consumer Staples
  • MRUS Health Care
  • Exchange
  • JJSF Nasdaq
  • MRUS Nasdaq
  • Market Cap
  • JJSF 3.3B
  • MRUS 2.9B
  • IPO Year
  • JJSF N/A
  • MRUS 2016
  • Fundamental
  • Price
  • JJSF $159.70
  • MRUS $41.85
  • Analyst Decision
  • JJSF Strong Buy
  • MRUS Strong Buy
  • Analyst Count
  • JJSF 1
  • MRUS 12
  • Target Price
  • JJSF $200.00
  • MRUS $87.92
  • AVG Volume (30 Days)
  • JJSF 86.2K
  • MRUS 670.1K
  • Earning Date
  • JJSF 02-03-2025
  • MRUS 10-31-2024
  • Dividend Yield
  • JJSF 1.89%
  • MRUS N/A
  • EPS Growth
  • JJSF 9.07
  • MRUS N/A
  • EPS
  • JJSF 4.45
  • MRUS N/A
  • Revenue
  • JJSF $1,574,755,000.00
  • MRUS $35,932,000.00
  • Revenue This Year
  • JJSF $5.79
  • MRUS N/A
  • Revenue Next Year
  • JJSF $3.60
  • MRUS $57.37
  • P/E Ratio
  • JJSF $35.98
  • MRUS N/A
  • Revenue Growth
  • JJSF 1.02
  • MRUS N/A
  • 52 Week Low
  • JJSF $133.23
  • MRUS $26.69
  • 52 Week High
  • JJSF $180.80
  • MRUS $61.61
  • Technical
  • Relative Strength Index (RSI)
  • JJSF 32.83
  • MRUS 39.11
  • Support Level
  • JJSF $159.96
  • MRUS $41.03
  • Resistance Level
  • JJSF $169.42
  • MRUS $45.25
  • Average True Range (ATR)
  • JJSF 3.54
  • MRUS 2.21
  • MACD
  • JJSF -1.22
  • MRUS 0.02
  • Stochastic Oscillator
  • JJSF 5.05
  • MRUS 10.15

About JJSF J & J Snack Foods Corp.

J&J Snack Foods Corp manufactures, markets, and distributes snack foods and beverages to foodservice and retail supermarket outlets. The company's products include frozen beverages, juice, fruit bars, sorbet, cakes, and cookies that are distributed to various consumers, including restaurants, supermarkets, convenience stores, universities, theaters, and theme parks. The company operates in three business segments: food service, which sells snacks, desserts, and baked goods at the point-of-sale; retail supermarkets, which sells frozen and prepackaged products to supermarkets; and frozen beverages, which sells frozen beverages under brands Icee, Slush puppie, and Parrot ice in the United States, Mexico, and Canada.

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

Share on Social Networks: